Injection Site Irritation Completed Phase 4 Trials for Lidocaine (DB00281)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0063115 (Injection Site Irritation) | Completed | 4 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01824758 | Effect of Esmolol on Pain Due to Rocuronium | Supportive Care | |
| NCT02524743 | The Prevention of Pain Associated With Rocuronium Injection | Treatment |